Pathology Ventures Appoints Dominic Stockey as Executive VP
Pathology Ventures taps former healthcare investment banker Dominic Stockey to lead sponsor and industry partnerships across its 500-plus pathologist network.
Pathology Ventures, LLC (PVL), a physician-founded network representing more than 500 pathologists, has named Dominic Stockey as Executive Vice President, the Shreveport, Louisiana-based organization announced September 29, 2026. Stockey brings a background in healthcare investment banking to the role, where he will focus on cultivating sponsor and industry partnerships for the group.
The appointment signals PVL's push to deepen its commercial relationships as the pathology field faces ongoing consolidation pressures and evolving reimbursement dynamics. By recruiting an executive with capital markets experience, the network appears to be positioning itself to attract strategic investment and industry collaboration on behalf of its physician members.
Read more Tectonic Therapeutic Reports Positive Phase 1 Data for Rare Vascular Drug TX2100 →
Stockey is expected to make his first major public appearance in the new role at the College of American Pathologists annual meeting, known as CAP26, scheduled for October 3–6 in Las Vegas. The conference represents a prime opportunity for PVL to introduce its new executive leadership to potential corporate and sponsor partners within the pathology and diagnostics community.
Founded and led by physicians, PVL has built its identity around independent pathologist representation at a time when large laboratory conglomerates have expanded their market share. The addition of a senior executive with an investment banking background may accelerate efforts to forge deals that preserve and expand the network's reach.
Continue reading at All Financial Services & Investing.
